Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A0001 in Patients With A3243G Mitochondrial DNA Mutation
NCT01074359Phase 2Terminated
- Sponsor
- Penwest Pharmaceuticals Co.
- Start
- Feb 2010
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alpha-tocopherolquinone, sponsored by Penwest Pharmaceuticals Co.. Started Feb 2010; status: terminated.
02
Drugs
alpha-tocopherolquinone
Beyond the preview
Go deeper on NCT01074359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01074359.